LEE BERMAN: Open Payments
NPI 1508271867 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 75 payments from 16 companies in 2025. Trend: 2023 $715 · 2024 $934 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $187 |
| Teva Pharmaceuticals USA, Inc. | 9 | $156 |
| HARMONY BIOSCIENCES LLC | 15 | $144 |
| Axsome Therapeutics, Inc. | 5 | $101 |
| Alkermes, Inc. | 5 | $86 |
| Supernus Pharmaceuticals, Inc. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Neurocrine BioSciences, Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| ACADIA Pharmaceuticals Inc | 2 | $33 |
Products named: VRAYLAR, WAKIX, Sunosi, AUSTEDO XR, Qelbree, ARISTADA, UZEDY, INGREZZA.
Industry payments across IA — which companies pay providers there.
